|
Statistical differences between patients with unexplained female sterility, patients with RPL and control subjects |
||||||||||
| Hcy (μM/ml) |
p |
Serum folate (ng/ml) |
P |
Serum vit. B 12 (pg/ml) |
p |
MTHFR C677T heterozigosity |
p |
MTHFR C677T homozigosity |
p |
|
|
|
||||||||||
| UFS vs CG |
21.05 ± 8.78 vs 7.85 ± 3.31 |
<0.01, s |
6.70 ± 4.50 vs 20.10 ± 9.44 |
<0.01, s |
648 ± 162 vs 664 ± 175 |
0.35, ns |
5/20 vs 9/20 |
0.32, ns |
15/20 vs 3/20 |
<0.01, s |
| UFS vs RPL |
21.05 ± 8.78 vs 19.20 ± 6.14 |
0.44, ns |
6.70 ± 4.50 vs 6.10 ± 2.81 |
0.007, s |
648 ± 162 vs 608 ± 154 |
0.42, ns |
5/20 vs 3/20 |
0.69, ns |
15/20 vs 17/20 |
0.69, ns |
| RPL vs CG |
19.20 ± 6.14 vs 7.85 ± 3.31 |
<0.01, s |
6.10 ± 2.81 vs 20.10 ± 9.44 |
<0.01, s |
608 ± 154 vs vs 664 ± 175 |
0.20, ns |
3/20 vs 9/20 |
0.08, ns |
17/20 vs 3/20 |
<0.01, s |
|
Hcy: homocysteine MTHFR: methylenetetrahydrofolate reductase UFS: unexplained female sterility group RPL: recurrent pregnancy loss group CG: control group ns: not significant s: significant | ||||||||||
D'Uva et al. Thrombosis Journal 2007 5:10 doi:10.1186/1477-9560-5-10 |
||||||||||